Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

A Study of Chinese Congenital Bicuspid Aortic Valve

A Cohort Study of Congenital Bicuspid Aortic Valve

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Pervious studies indicated that the prevalence of bicuspid aortic valve(BAV) might be higher in China. There is a familial predisposition to the development of BAV. The study analyzed epidemiological data on selected BAV and established a BAV cohort to observe disease progression and treatment outcomes.

Who May Be Eligible (Plain English)

Who May Qualify: - The patients were aged 14-60 years; - Definitive diagnosis of BAV by imaging (echocardiography, aortic CTA, cardiac magnetic resonance, etc.) - Patients were informed about the nature of the study and agreed to participate in all the terms of the study and signed an willing to sign a consent form form approved by the ethics committee. Who Should NOT Join This Trial: - Poor patient compliance and inability to complete follow-up visits as required; - Rheumatic heart valve disease, other organic valve disease. - Hyperthyroidism, severe anemia, and other factors that significantly affect hemodynamics. - Other circumstances that the researcher believes should be excluded. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * The patients were aged 14-60 years; * Definitive diagnosis of BAV by imaging (echocardiography, aortic CTA, cardiac magnetic resonance, etc.) * Patients were informed about the nature of the study and agreed to participate in all the terms of the study and signed an informed consent form approved by the ethics committee. Exclusion Criteria: * Poor patient compliance and inability to complete follow-up visits as required; * Rheumatic heart valve disease, other organic valve disease. * Hyperthyroidism, severe anemia, and other factors that significantly affect hemodynamics. * Other circumstances that the researcher believes should be excluded.

Locations (1)

Ruijin hospital, Shanghai JiaoTong University School of Medicine
Shanghai, Shanghai Municipality, China